DiaMonTech collects 5 million euros

Berlin, 4 September 2018

DiaMonTech GmbH, a start-up specializing in non-invasive blood glucose measurement methods, has successfully completed its second financing round. In total, the company will receive around 5 million euros from old and new investors. The IBB Beteiligungsgesellschaft from Berlin, the Japanese electronics group Macnica and the Chinese venture capitalist Jindong Capital are the largest investors. DiaMonTech intends to use the money to advance the development of non-invasive blood glucose monitoring with its patented optical method.

Stay tuned and get updates.

Notify Me